ReviewFrontiers in immunology2023

Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives.

Osman Dadas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.